Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Market
financetom
/
Market
/
Japan's Nikkei hits record high on Wall Street gains, weaker yen
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024 8:36 PM
Previous page:
Inox Wind board approves preferential issue of Rs 400 cr to reduce debt
Next page:
Reliance Industries, ACC, L&T Infotech and more: Key stocks that moved the most on April 20
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Inox Wind board approves preferential issue of Rs 400 cr to reduce debt
Apr 20, 2022
Inox Wind stock is buzzing in trade as the company’s board approved preferential allotment of Rs 402 crore. The promoters – Inox Leasing & Finance will raise Rs 150 crore equity and the balance will be raised from non-promoters. Devansh Jain, Whole-time Director of Inox Wind in an interview to CNBC-TV18 said the company plans to use the funds for debt reduction.
Reliance Industries, ACC, L&T Infotech and more: Key stocks that moved the most on April 20
Apr 20, 2022
Indian benchmark indices closed over a percent higher with Nifty50 ending at 17,136.50 and Sensex closing at 57,037.50. Here are key stocks that moved the most in today's trading session -
L&T Technology Q4FY22 dollar revenue likely to grow by 4.4%
Apr 20, 2022
L&T Technology is scheduled to report its Q4FY22 earnings on Thursday. CNBC-TV18's poll expects its dollar revenue to grow by 4.4 percent at $235 million versus $225.1 million in Q3FY22.
Gufic Biosciences stock up 10.56% after minor stake buy in Australian biotech firm Selvax
Apr 20, 2022
Gufic Biosciences has acquired a 2.67 percent stake in Australian biotech company, Selvax, for around $1,00,000. The company said the deal would help them fast-forward their immuno oncology research efforts.
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2025 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP